SCLC cell lines exhibit considerable heterogeneity as regards morphology, biochemistry and growth kinetics (Carney et al., 1985a) . 'Classic' SCLC lines commonly grow as floating aggregates (morphology type I or II) and possess neurosecretory granules (NSG) on electron microscopy. They express four biomarkers: creatine kinase-BB (CK-BB), neurone specific enolase (NSE), dopa decarboxylase (DDC) and bombesin-like immunoreactivity (BLI), the latter attributable to the mammalian homologue of bombesin, gastrin releasing peptide (GRP; Brown et al., 1980) . 'Variant' cultures usually grow in suspension as single cells or loose clusters (type III morphology), or as an adherent monolayer (type IV). They proliferate more rapidly than the classic lines, lack NSG and fail to express DDC and BLI (Carney et al., 1985a) . Recent work suggests a special role for bombesin/GRP in SCLC. The cells possess specific, high affinity bombesin receptors (Moody et al., 1983) . Bombesin (or the bombesin-homologous fragment of GRP, residues 14-27) is mitogenic for SCLC in vitro (Weber et al., 1985; Carney et al., 1987) . Finally, an antibombesin monoclonal antibody has been shown (Cuttitta et al., 1985) to inhibit SCLC growth in vitro and in vivo. Thus there is good evidence that bombesin/GRP functions as an autocrine growth factor in classic SCLC. However this is may not explain rapid growth in variant lines, since these lack BLI.
Suspecting that SCLC may produce more than one growth factor, we developed a novel mitogenicity assay to investigate potential autocrine phenomena in 5 human lung lines.
HC12 is a classic SCLC line (see Table I ) which was grown from a malignant pericardial effusion in a patient with chemo-and radio-resistant SCLC (Duchesne et al., 1987) . In our laboratory it has been grown continuously (12 months to date) in RPMI medium alone, without added foetal calf serum (FCS) or HITES (hydrocortisone, insulin, transferrin, oestradiol and sodium selenite; Simms et al., 1980) . Proliferation of SCLC in such restricted conditions has only recently been described and may reflect increased production of autocrine growth factor(s). This phenomenon merits attention since it provides a clean system in which to investigate endogenous factor secretion and to determine the effect of exogenously added factors.
HC12 cells in RPMI alone were passaged at confluence every 10-14 days. The conditioned medium was centrifuged (2,000rpm, 5min) to remove cell debris, stored at -20°C and concentrated ')y lyophilisation and reconstitution in aqueous solution. Hyperosmolarity was corrected by dialysis against 0.9% saline' across Visking cellulose membrane (Medicell International Ltd.; pore size 2.4nm, approximate MW cut-off 10-12 kDa). The final preparation (CM) plates were incubated in a humidified atmosphere of 10% C02, 5% 02 and 85% N2. After 30h, the wells were serially labelled with a combined preparation of 14C-thymidine (0.4,uCi per well), 3H-uridine (0.4pCi) and 75seleno-methionine (0.08pCi; Amersham, UK) in a total volume of 10pl per well. After 70h, the cells were collected onto filter paper discs, and the DNA, RNA and protein were precipitated with ice-cold 5% trichloroacetic acid (TCA), and counted. A calibration curve was prepared to assess and correct for spurious beta counts generated by the gamma emitter.
GRP was tested at a range of concentrations spanning that which Weber et al. (1985) found most mitogenic. GRP 1-27 (0.1-100pgml-1) failed to stimulate uptake of any label above the control level. Label uptake was reduced below the control level by GRP 1-16 (0.5-50ygml-1). Significant enhancement of 14C-thymidine uptake was seen only with the bombesin-homologous fragment GRP14-27: at 5 and 50 pg ml-', mean label uptake at 24 h was increased by 330% and 230% respectively over the control level (P<0.01 in each case). Lesser effects were seen at 0.5pgml-1 (119% of control at 24h, NS). Stimulation of RNA and protein synthesis was generally less marked; GRP14-27 at 5 and 50 ug mlP-caused an increase in 3H-uridine uptake amounting to 130% of control values at 24h (P<0.05). 75Selenomethionine uptake was enhanced by both 5 and 50pgml-1 at 24h (132% and 116% of control, NS). These results are illustrated in Figure 1 , which for clarity shows only the most mitogenic concentrations of the whole GRP molecule or fragments. Weber et al. (1985) showed comparable effects on DNA synthesis (250-300% increase in 3H-thymidine uptake at 20h) with GRPP14-27 at 5igml-1.
However their reported GRP concentrations may be inaccurate, since they used RPMI with 10% FCS (rather than RPMI alone) in all wells; FCS has recently been shown to contain GRP (Wiedermann et al., 1986) .
In wells supplemented with CM there was more striking evidence ( Figure 1) (including accumulated error after correction of ,B counts) of three wells. Where no error bars are shown, the s.e.m. is smaller than the symbol used to represent the mean. The 24h data were assessed by analysis of variance; mitogenic effects were compared with control values using a twotailed Dunnett's test, and all other comparisons used Tukey's test (Zar, 1984) . the putative HC12-derived growth factor by targetting the CM against the other human lung lines. These were two classic SCLC lines, HX149 and NCI-H69, one variant, ICR-SC17, and a large cell anaplastic line, HX147 (see Table I for source and characterisation data). Having shown linear uptake of label with time, subsequent experiments used only a single time point, 24 h incubation with label.
Both classic lines showed clear enhancement of DNA synthesis in wells supplemented with HC12 CM (Figure  3a, b) . 14C-thymidine uptake was increased over control levels in HX149 by 360% (P<0.001) and in NCI-H69 by 230% (P<0.001). RNA synthesis was also significantly enhanced (P<0.001) in both lines, as was protein synthesis in NCI-H69 (150% over control, P<0.01) but not in HX149 (90%).
The variant SCLC line ICR-SC17 responded (Figure 3c Time (days) Time (days) Figure 2 Effect of CM on HC12 label uptake and cell number. To confirm label-uptake results obtained with HC12 CM, duplicate pairs of plates were set up as previously described. On each of three subsequent days, after 24h pulse labelling, one plate was harvested by TCA precipitation to assess label uptake, and in the other, viable cell numbers were counted on a haemocytometer by trypan blue exclusion. The day 4 data were analysed for significant differences by Student's t-test. i. 14C-Thymidine protein synthesis were enhanced by 140% (P<0.05), 240% (P<0.001) and 200% (P<0.001) respectively over control levels. Finally the CM was targetted against a non-SCLC line, HX147 (Figure 3d) . A modest (130%, P<0.01) increase in 14C-thymidine uptake was observed, but there was no effect on RNA or protein synthesis.
We have taken preliminary steps to isolate and characterise the HC12-derived growth factor activity. CM was separated by reverse-phase HPLC (column packing Ultrapore RPSC 5 pm, Beckman) using a saline/acetonitrile mobile phase at pH2, 45°C. Three fractions (0-20%, 20-40% and 40-60% acetonitrile) were eluted and were tested in the triple label uptake assay. Biological activity was contained in the 40-60% acetonitrile fraction (data not shown), indicating that the putative growth factor is hydrophobic and acid-stable. Further identification is planned.
In summary, we present here the results of studies on a classic SCLC cell line, HC12, which grows continuously in RPMI medium alone. We have used a novel assay to test the mitogenic potential of HC12-derived CM. A high mol. wt preparation, depleted of BLI, has been shown to enhance nucleotide and protein synthesis in HC12 and also, notably, in three other SCLC lines. We conclude that the growth factor activity described here is immunologically unrelated to bombesin, and is probably of high mol. wt (>10 kDa).
